Abstract
No public abstract is available from the verified source records.
Th. Gallarda, H. Lôo
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
The glutamatergic system and neurodegeneration in dementia : preventive strategies in Alzheimer's disease
10.1002/(sici)1099-1166(199901)14:1<3::aid-gps897>3.0.co;2-7 · 1999
The Neuropsychiatric Inventory : comprehensive assessment of psychopathology in dementia
10.1212/wnl.44.12.2308 · 1994
Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease – a unified glutamatergic hypothesis on the mechanism of action
10.1007/bf03033787 · 2000
Alzheimer's disease : a public health problem : yes but a priority ?
2002
Efficacy and tolerability of memantine in patients with dementia syndrome-A double-blind, placebo-controlled trial
1991
Unresolved referenced work
Kept as external metadata until matched
Système cholinergique et traitement de la maladie d’Alzheimer
2001
Unresolved referenced work
Kept as external metadata until matched
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
10.1212/wnl.57.4.613 · 2001
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
« Mini Mental State » : a practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · 1975
Epidemiology of dementia
2001
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Memantine in the treatment of mild to moderate dementia syndrome-a double-blind placebo-controlled study
1992
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
10.1097/00004850-200303000-00003 · 2003
A new clinical scale for the staging of dementia
10.1192/bjp.140.6.566 · 1982
Unresolved referenced work
Kept as external metadata until matched
Potential and current use of N-Methyl-D-Aspartate (NMDA) receptor antagonists in diseases of aging
10.2165/00002512-200118100-00001 · 2001
Unresolved referenced work
1990
Prévalence de la démence en Gironde (France)
1993
Théorie de l’excitotoxicité. Implication potentielle des acides aminés excitateurs dans les processus dégénératifs
2001
Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate
10.1126/science.164.3880.719 · 1969
Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300)
10.1161/01.str.0000020094.08790.49 · 2002
Batterie d’évaluation neuropsychologique pour la démence grave
1992
Unresolved referenced work
Kept as external metadata until matched
Glutamate in CNS disorders as a target for drug development : an update
10.1358/dnp.1998.11.9.863689 · 1998
Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data
10.1016/s0028-3908(99)00019-2 · 1999
Unresolved referenced work
2002
Prévalence de la démence et de la maladie d’Alzheimer chez les personnes âgées de 75 ans et plus : données réactualisées de la cohorte PAQUID
2003
Functional staging of dementia of the Alzheimer's type
10.1111/j.1749-6632.1984.tb13859.x · 1984
The Global Deterioration Scale for assessment of primary degenerative dementia
10.1176/ajp.139.9.1136 · 1982
Memantine in moderate-to-severe Alzheimer's disease
10.1056/nejmoa013128 · 2003
Unresolved referenced work
2000
Functional Assessment Staging (FAST)
1988
A prospective PMS study to validate the sensitivity for change of the D-Scale in advanced Stages of dementia using the NMDA-antagonist Memantine
10.1055/s-2000-341 · 2000
Assessment of the severely impaired patient : description and validation of a new neuropsychological test battery
10.1037/1040-3590.2.3.298 · 1990
Memantine in severe dementia : results of the 9M-best study (benefit and efficacy in severely demented patients during treatment with memantine)
10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0 · doi-reference
Glutamate receptors as a target for Alzheimer's disease – are clinical results supporting the hope ?
10.1007/978-3-7091-6139-5_20 · doi-reference
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
10.1001/jama.291.3.317 · doi-reference
Measuring cognition in advanced Alzheimer's disease for clinical trials
10.1007/978-3-7091-6139-5_14 · doi-reference